| Rosalinda R Yparraguirre, RPH | |
|
16020 Perris Blvd, Moreno Valley, CA 92551-4618 | |
| (951) 247-2113 | |
| Not Available |
| Full Name | Rosalinda R Yparraguirre |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 16020 Perris Blvd, Moreno Valley, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811274087 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 42434 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rosalinda R Yparraguirre, RPH 8466 Sunshine Ln, Riverside, CA 92508-7115 Ph: (951) 780-8106 | Rosalinda R Yparraguirre, RPH 16020 Perris Blvd, Moreno Valley, CA 92551-4618 Ph: (951) 247-2113 |
News Archive
ArQule, Inc. today announced the pricing of an underwritten public offering of 7,150,000 shares of its common stock at a price of $7.30 per share.
The U.S. Food and Drug Administration has approved IXIARO, a vaccine to prevent Japanese encephalitis (JE) which is caused by a mosquito-transmitted virus found mainly in Asia. IXIARO will be the only vaccine for JE available in the United States.
Cells from healthy individuals with major depressive disorder were found to have higher than expected rates of methylation at specific sites on their DNA, when compared to cells from healthy individuals without MDD, according to a study by a multidisciplinary team of Walter Reed Army Institute of Research and University of California San Francisco scientists, in collaboration with others.
Essentialis, Inc. announced today that the United States Patent & Trademark Office (USPTO) has issued U.S. Patent No. 7,799,777 entitled Salts of potassium ATP channel openers and uses thereof. The patent claims a novel composition of a polymorph of diazoxide choline, the active ingredient in the Essentialis lead product, DCCR. Essentialis has successfully completed phase 2b clinical trials with DCCR, showing a highly significant triglyceride reduction in dyslipidemic patients.
› Verified 5 days ago
Osama Bishay, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 24991 Alessandro Blvd, Moreno Valley, CA 92553 Phone: 951-485-4450 | |
Dr. Thu Kieu Nguyen Huynh, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4613 | |
Hong My Lam, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12275 Perris Blvd, Moreno Valley, CA 92557 Phone: 951-242-8717 | |
Grace Shinn, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4000 | |
Dr. Chi Wah Simon Chou, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 25011 Alessandro Blvd, Moreno Valley, CA 92553 Phone: 951-485-1116 | |
Oksana Niknafs, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 26520 Cactus Ave, Moreno Valley, CA 92555 Phone: 951-486-4515 | |
Dr. Linda Tang Ortega, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23965 Ironwood Ave, Moreno Valley, CA 92557 Phone: 951-242-1742 Fax: 951-242-7291 |